Search bioRxivSearch

Biology subjects

Mitchell, J. M.

Publications and source records attributed to Mitchell, J. M..

2 recordsLinked to original sources

Inferring metabolite interactomes via molecular structure informed Bayesian graphical model selection with an application to coronary artery disease

IntroductionWhile the generation of reference genomes facilitates the elucidation of gene-phenome associations, reference models of the metabolome that are specific to organism, sample type (e.g. plasma, serum, urine, cell-culture), and state (including disease), remain uncommon. In studying heart disease in humans, a reference model describing the relationships between metabolites in plasma has not been determined but would have great utility as a reference for comparing acute disease states such as myocardial infarction.\n\nMaterials and MethodsWe present a methodology for deriving probabilistic models that describe the partial correlation structure of metabolite distributions (\"interactomes\") from metabolomics data. As determining partial correlation structures requires estimating p*(p-1)/2 parameters for p metabolites, the dimension of the search space for parameter values is immense. Consequently, we have developed a Bayesian methodology for the penalized estimation of model parameters in which the magnitude of penalization is drawn from probability distributions with hyperparameters linked to molecular structure similarity. In our work, structural similarity was determined as the Tanimoto coefficient of algorithmically-generated \"atom colors\" that capture the local structure around each atom within each structure. A Gibbs sampler (a Markov chain Monte Carlo technique) was implemented for simulating the posterior distribution of model parameters. We have made software for implementing this methodology publicly available via the R package BayesianGLasso.\n\nResults / ConclusionsFirst, we demonstrate robust performance of our methodology (sensitivity, specificity, and measures of accuracy) for recovering the true underlying partial correlation structure over simulated datasets (with simulated metabolite abundances and simulated known structural similarity). We then present an interactome model for stable heart disease inferred from non-targeted mass spectrometry data via this methodology. Inspection of the local graph topology about cholate reveals probabilistic interactions with other primary bile acids, secondary bile acids, and many steroid hormones sharing the same precursors.

systems biology

High Peak Density Artifacts in Fourier Transform Mass Spectra and their Effects on Data Analysis

Fourier-transform mass spectrometry (FT-MS) allows for the high-throughput and high-resolution detection of thousands of metabolites. Observed spectral features (peaks) that are not isotopologues do not directly correspond to known compounds and cannot be placed into existing metabolic networks. Spectral artifacts account for many of these unidentified peaks, and misassignments made to these artifact peaks can create large interpretative errors. Without accurate identification of artifactual features and correct assignment of real features, discerning their roles within living systems is effectively impossible.\n\nWe have observed three types of artifacts unique to FT-MS that often result in regions of abnormally high peak density (HPD), which we collectively refer to as HPD artifacts: i) fuzzy sites representing small regions of m/z space with a fuzzy appearance due to the extremely high number of peaks present; ii) ringing due to a very intense peak producing side bands of decreasing intensity that are symmetrically distributed around the main peak; and iii) partial ringing where only a subset of the side bands are observed for an intense peak. Fuzzy sites and partial ringing appear to be novel artifacts previously unreported in the literature and we hypothesize that all three artifact types derive from Fourier transformation-based issues. In some spectra, these artifacts account for roughly a third of the peaks present in the given spectrum. We have developed a set of tools to detect these artifacts and approaches to mitigate their effects on downstream analyses.

systems biology